2 Registered trials

0 Recruiting

1 Unique sponsors

2 Unique IMPs

2 Commercial trials

Drug classes (ATC)

— ATC code not specified 1

L Oncology (ATC L) 1

Mechanism of action (INN-stem analysis)

Checkpoint inhibitor (PD-1) 1 substance

Antimetabolite 1 substance

Phase III

Phase I (Other)

Phase III: 1 Phase I (Other): 1

Filter these 2 trials by country, sponsor, date range and more.

Phase III

1 trial

Phase I (Other)

1 trial

Sponsor activity

Sponsor	Type	Trials	Phases	Recruiting
H e x a l AG	Commercial	2	Phase I (Other), Phase III	0

New trials by year

2024